Lantheus Holdings, Inc.'s Form 4 filing
Perspective Therapeutics, Inc.CATX · filed Mar 8, 2024
- Accession no.
- 0000950170-24-028446
- Filed
- Mar 8, 2024, 11:24 AM ET
- Trade date
- Mar 6, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction. Open-market purchases total $57.4M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lantheus Holdings, Inc.CIK 0001521036 | 10% Owner |
| Lantheus Alpha Therapy, LLCCIK 0002010224 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 6, 2024 | Common Stock | PPurchaseAcquired | +60,431,039 | $0.95 | +$57,409,487.05 | 116,773,394 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.